GMAB · Genmab A/S
$31.94
+0.60 (+1.91%)
At close · Aug 14
Market Cap
$19.63B
Shares
614.62M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-12 | — | |
| 6-K | 2026-08-11 | — | |
| 6-K | 2026-08-06 | 2026-06-30 | |
| 6-K | 2026-07-15 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-17 | — | |
| 6-K | 2026-06-16 | — | |
| 6-K | 2026-06-15 | — | |
| 6-K | 2026-06-15 | — | |
| 6-K | 2026-06-11 | — | |
| 6-K | 2026-05-29 | — | |
| 6-K | 2026-05-13 | — | |
| 6-K | 2026-05-12 | — | |
| 6-K | 2026-05-08 | — | |
| 6-K | 2026-05-07 | — | |
| 6-K | 2026-04-17 | — | |
| 6-K | 2026-04-17 | — | |
| 6-K | 2026-04-14 | — | |
| 6-K | 2026-04-14 | — | |
| 6-K | 2026-04-01 | — | |
| 6-K | 2026-04-01 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| 6-K | 2026-03-30 | — | |
| 6-K | 2026-03-23 | — | |
| 6-K | 2026-03-19 | — | |
| 6-K | 2026-03-19 | — | |
| 6-K | 2026-03-16 | — | |
| 6-K | 2026-03-09 | — | |
| 6-K | 2026-03-04 | — | |
| 6-K | 2026-03-03 | 2026-03-02 | |
| 6-K | 2026-03-02 | — | |
| 6-K | 2026-02-27 | — | |
| 6-K | 2026-02-25 | — | |
| 6-K | 2026-02-24 | — | |
| 6-K | 2026-02-23 | — | |
| 6-K | 2026-02-20 | — | |
| 6-K | 2026-02-18 | — | |
| 20-F | 2026-02-17 | 2025-12-31 | |
| 6-K | 2026-02-17 | — | |
| 6-K | 2026-02-03 | — | |
| 6-K | 2026-01-29 | — | |
| 6-K | 2026-01-21 | — | |
| 6-K | 2026-01-16 | — | |
| 6-K | 2025-12-29 | — | |
| 6-K | 2025-12-12 | — | |
| 6-K | 2025-12-01 | — | |
| 6-K | 2025-11-26 | — | |
| 6-K | 2025-11-20 | — | |
| 6-K | 2025-11-19 | — | |
| 6-K | 2025-11-19 | — |
Showing 1–50 of 455 filings
Key facts
CIK
1434265
CUSIP
372303206
13F (30d)
290 filings
264 filers
Visit website
Investor relations